| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 09/20/2006 | CN1275961C Photoactive dicyclic alcohol and its prepn, medicinal composition and use |
| 09/20/2006 | CN1275954C Hydroxamic acid derivatives |
| 09/20/2006 | CN1275938C Thyroid hormone receptor atagonists for treating cardiac and metabolic disorders II |
| 09/20/2006 | CN1275647C Application of neutral proteinase in preparing medicine for anorectal diseases and the medicine |
| 09/20/2006 | CN1275646C Nose drops of recombined human interferon alpha 2b and preparing method |
| 09/20/2006 | CN1275645C Changsanye-factor oral liquor and clinical use |
| 09/20/2006 | CN1275640C Medicine for treating chromic avidity, persistent hepatitis B and its preparation method |
| 09/20/2006 | CN1275637C Medicine for treating oral disease |
| 09/20/2006 | CN1275627C Medicine for treating insufficiency of the kidney-yang syndrome and its preparing method |
| 09/20/2006 | CN1275624C Application of glossy ganoderma spore powder for pharmaceutical preparation |
| 09/20/2006 | CN1275621C Extract product of Chinese traditional medicine as well as preparation method and application |
| 09/20/2006 | CN1275615C Levulose absorption retardant, compound, food and levulose absorption repressor |
| 09/20/2006 | CN1275612C Health care food for improving stomach and intestine functions |
| 09/20/2006 | CN1275608C Medicine for treating oral cavity ulcer and method for preparing same |
| 09/20/2006 | CN1275607C Medicinal composition for treating hyperhydrochloria, its preparing method and use |
| 09/20/2006 | CN1275606C Medical usage of simonder wood oil |
| 09/20/2006 | CN1275605C Guibiegongjiang capsule and its preparation method |
| 09/20/2006 | CN1275601C Composition and method of tissue superoxygenation |
| 09/20/2006 | CN1275594C Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 09/20/2006 | CN1275551C Green healthy beverage |
| 09/19/2006 | US7109361 Isolation of lutein from alfalfa |
| 09/19/2006 | US7109354 Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 09/19/2006 | US7109342 Antiinflammatory agents; antiallergens; autoimmune diseases |
| 09/19/2006 | US7109296 Used to identify modulators of the 5-HT3 serotonin receptor complex, and to reconstitute a more realistic physiological 5-HT3 receptor response in recombinant systems |
| 09/19/2006 | US7109231 Antiinflammatory agents; sepsis |
| 09/19/2006 | US7109210 substituted with (hetero)aryl carbonyloxy group and quaternized, e.g., 3(R)-Diphenylacetoxy-1-(3-phenoxy-propyl)-1-azoniabicyclo[2.2.2]octane; bromide; antimuscarinic agents for treating COPD, chronic bronchitis, asthma and rhinitis. |
| 09/19/2006 | US7109202 Such as 3-(2-(6-methyl-pyridin-2-ylamino)-5-(1,2,4)triazol-1-yl-thiazol-4 -yl)benzonitrile for treatment of inflammatory or obstrucive airways diseases |
| 09/19/2006 | US7109176 For therapy of inflammatory diseases and conditions in humans and animals |
| 09/19/2006 | US7109166 A piperazine-somatostatin analog in sustained release ionic conjugate with lactic acid-glycolic acid-tartaric acid copolymer; for therapy of gastrointestinal disorders, such as Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, VIPoma, nesidoblastosis |
| 09/19/2006 | US7109160 Peptides containing the motif IGD and their use as cell migration modulators |
| 09/19/2006 | US7108868 Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia |
| 09/19/2006 | CA2292558C 1-amino-alkylcyclohexane nmda receptor antagonists |
| 09/19/2006 | CA2232195C Isoxazolidine derivatives |
| 09/19/2006 | CA2083396C Derivatives of human bile-salt stimulated lipase, and pharmaceutical compositions containing them |
| 09/14/2006 | WO2006096802A1 Amorphous tegaserod maleate |
| 09/14/2006 | WO2006096591A1 Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol and their use as estrogen receptor modulators |
| 09/14/2006 | WO2006096016A1 Pharmaceutical composition comprising migb compound for improving gastrointestinal dyskinetic diseases. |
| 09/14/2006 | WO2006095906A1 Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient |
| 09/14/2006 | WO2006095858A1 Composition for treating bacterial disease in the oral cavity, liquid agent for washing treatment, liquid agent for hemostasis treatment and method of treating bacterial disease in the oral cavity |
| 09/14/2006 | WO2006095711A1 Method of regenerating or repairing damaged tissue by using adrenomedulin |
| 09/14/2006 | WO2006095704A1 Method of treating liver cancer |
| 09/14/2006 | WO2006095671A1 Novel salt of quinuclidine derivative |
| 09/14/2006 | WO2006095433A1 Therapeutic agent for bovine digestive system disease |
| 09/14/2006 | WO2006094904A1 Process for the preparation of optically active derivatives of 2-(2-pyridylmethylsulfinyl)-benzimidazole via inclusion complex with 1,1'-binaphthalene-2, 2'diol |
| 09/14/2006 | WO2006094451A1 The use of hydrochloric acid for the manufacture of a medicament for the treatment of hypertension |
| 09/14/2006 | US20060205819 Methods of treatment inflammatory bowel with lxr agonists |
| 09/14/2006 | US20060205791 Pharmaceutical process and compounds prepared thereby |
| 09/14/2006 | US20060205770 Acid addition salts such as (-)-(3R)-quinuclidin-3-yl(1R)-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate (-)-(2S,3S)-tartrate; for treatment of various M3 receptor-mediated diseases such as urinary incontinence, respiratory diseases such as chronic obstructive pulmonary disease |
| 09/14/2006 | US20060205734 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/14/2006 | US20060205715 6-(8-Pentylamino-5,6,7,8-tetrahydro-naphthalen-2-yloxy)-nicotinamide; increase metabolic energy consumption, and reduction of weight; obesity, antidiabetic agent, eating disorders; antidepressant, anxiolytic agent |
| 09/14/2006 | US20060205712 e.g. N-[2-[4-(2-(S)-amino-6-dimethylamino-hexanoyl)-piperazin-1-yl]-1,1-dimethyl-2-oxo-ethyl]-2,4-dichloro-3-(2-methyl -quinolin-8-yloxy-methyl)-benzensulfonamide trifluoroacetate; antiinflammatory agent; asthma, chronic bronchitis, allergic rhinitis, obstructive pulmonary disease (COPD) |
| 09/14/2006 | US20060205710 Spiroazacyclic compounds as monoamine receptor modulators |
| 09/14/2006 | US20060205708 such as 4-methoxybenzaldehyde O-{2-[3-(3-ethoxy-4-methoxyphenyl)-5,6-dihydro-4H-pyridazin-1-yl]-2-oxoethyl}oxime; phosphodiesterase IV inhibitors |
| 09/14/2006 | US20060205686 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 09/14/2006 | US20060205676 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one |
| 09/14/2006 | US20060205659 Peptide radical having 5-25 amino acids with its N-terminus capped with a monoester of fumaric acid; used to treat autoimmune diseases, mitochondrial diseases, and NF-kappaB mediated diseases and in transplantation medicine |
| 09/14/2006 | US20060205655 Nucleic acids encoding (poly) peptides having CHIPS activity |
| 09/14/2006 | US20060205021 Mammalian IAP gene family, primers, probes and detection methods |
| 09/14/2006 | US20060205018 Polypeptides which have zinc metalloprotease activities and are referred to as IGS5, and polynucleotides encoding such polypeptides; use in therapy |
| 09/14/2006 | US20060204591 Treatment of mucosal membranes |
| 09/14/2006 | US20060204549 Method of improving nutrient utilisation by a mammal and a composition for use therein |
| 09/14/2006 | CA2600358A1 Method for treatment of hepatic cancer |
| 09/14/2006 | CA2600339A1 Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol and their use as estrogen receptor modulators |
| 09/14/2006 | CA2599879A1 Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient |
| 09/14/2006 | CA2599872A1 Novel salt of quinuclidine derivative |
| 09/13/2006 | EP1700858A1 Salts of a quinuclidine derivative as muscarinic M3 receptor antagonists |
| 09/13/2006 | EP1700603A2 Immunostimulatory nucleic acids |
| 09/13/2006 | EP1700597A1 Pharmaceutical composition containing in association ubidecarenone, dexpanthenol and chlorhexidine or a pharmaceutically acceptable salt thereof for cutaneous application |
| 09/13/2006 | EP1699495A2 Conjugates of angiotensin ii and an imaging moiety |
| 09/13/2006 | EP1699471A1 Pharmaceutical active ingredient against hepatitis |
| 09/13/2006 | EP1699454A1 Pyrazole derivatives and use thereof as orexin receptor antagonists |
| 09/13/2006 | EP1699447A1 Compositions comprising pantothenic acid or derivatives thereof and their use for stimulating appetite |
| 09/13/2006 | EP1513942B1 Galactosyl isomalt, method for production and use thereof |
| 09/13/2006 | EP1497662B1 Uses of the carbamoyl phosphate synthesis 1 (cps 1) and the fragments thereof for the diagnosis of sepsis |
| 09/13/2006 | EP1497274B1 Terphenyl derivatives, preparation thereof, compositions containing same |
| 09/13/2006 | EP1442050B1 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 09/13/2006 | EP1395252B1 Medicaments for treating colics |
| 09/13/2006 | EP1389206B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 09/13/2006 | EP1284720B1 L-fmau for the treatment of hepatitis delta viral infection |
| 09/13/2006 | EP1282643B1 Anti-inflammatory compounds and uses thereof |
| 09/13/2006 | EP1230215B1 Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 09/13/2006 | EP1218358B1 Therapeutic quinazoline compounds |
| 09/13/2006 | EP1196579B1 Tryptase inhibitor |
| 09/13/2006 | EP1179344B1 Release-regulating preparations |
| 09/13/2006 | EP1087951B9 Carbon substituted aminothiazole inhibitors of cyclin dependent kinases |
| 09/13/2006 | CN1832959A Polyethelene glycol link glp-1 compounds |
| 09/13/2006 | CN1832948A 1- alkyl-1-azoniabicyclo (2.2.2) octane carbamate derivatives and their use as muscarinic receptor antagonists |
| 09/13/2006 | CN1832945A Diphenylpyridine derivatives, preparation and therapeutic application thereof |
| 09/13/2006 | CN1832935A Therapeutic agents useful for treating pain |
| 09/13/2006 | CN1832934A Benzoxazepine-based compound |
| 09/13/2006 | CN1832751A Periodontal disease therapeutic and/or preventive composition |
| 09/13/2006 | CN1832749A Viscosity-Stable bismuth-containing pharmaceutical compositions. |
| 09/13/2006 | CN1832728A Process for producing drug ultramicroparticle and apparatus therefor |
| 09/13/2006 | CN1831121A Method for structuring hybridoma cell system for anti-human monoclonal antibody of hepatitis B virus and its application |
| 09/13/2006 | CN1830978A Pyrazolo [4,3c]-quinolin-3-one compound, prepn. method and use thereof |
| 09/13/2006 | CN1830484A Memicine for treating body cold due to deficiency of blood and its preparation method |
| 09/13/2006 | CN1830474A Medicinal wine and its manufacturing method |
| 09/13/2006 | CN1830463A Chinese medicinal preparation for treating toothache |
| 09/13/2006 | CN1830448A Aldfuwei ester injection having liver target and its preparation method |
| 09/13/2006 | CN1830444A Preparation method of Sophora flavescems injection |